Filing Details
- Accession Number:
- 0000920465-19-000011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-09 21:29:45
- Reporting Period:
- 2019-01-07
- Accepted Time:
- 2019-01-09 21:29:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920465 | La Jolla Pharmaceutical Co | LJPC | Biological Products, (No Disgnostic Substances) (2836) | 330361285 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1287235 | F George Tidmarsh | C/O La Jolla Pharmaceutical Company, 4550 Towne Centre Court San Diego CA 92121 | President, Ceo & Secretary | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-01-07 | 82 | $5.85 | 1,281,408 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-07 | 287 | $5.85 | 1,281,695 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-07 | 98 | $5.85 | 1,281,793 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-07 | 397 | $5.85 | 1,282,190 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-07 | 700 | $5.85 | 1,282,890 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-07 | 436 | $5.85 | 1,283,326 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 22,000 | Indirect | By children |
Billionaire Hedge Funds
